Circulating let-7g is down-regulated in Bernese Mountain dogs with disseminated histiocytic sarcoma and carcinomas: a prospective study

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Circulating let-7g is down-regulated in Bernese Mountain dogs with disseminated histiocytic sarcoma and carcinomas : a prospective study. / Børresen, B; Nielsen, L N; Jessen, L R; Kristensen, A T; Fredholm, M; Cirera Salicio, Susanna.

I: Veterinary and Comparative Oncology, Bind 15, Nr. 2, 06.2017, s. 525–533.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Børresen, B, Nielsen, LN, Jessen, LR, Kristensen, AT, Fredholm, M & Cirera Salicio, S 2017, 'Circulating let-7g is down-regulated in Bernese Mountain dogs with disseminated histiocytic sarcoma and carcinomas: a prospective study', Veterinary and Comparative Oncology, bind 15, nr. 2, s. 525–533. https://doi.org/10.1111/vco.12196

APA

Børresen, B., Nielsen, L. N., Jessen, L. R., Kristensen, A. T., Fredholm, M., & Cirera Salicio, S. (2017). Circulating let-7g is down-regulated in Bernese Mountain dogs with disseminated histiocytic sarcoma and carcinomas: a prospective study. Veterinary and Comparative Oncology, 15(2), 525–533. https://doi.org/10.1111/vco.12196

Vancouver

Børresen B, Nielsen LN, Jessen LR, Kristensen AT, Fredholm M, Cirera Salicio S. Circulating let-7g is down-regulated in Bernese Mountain dogs with disseminated histiocytic sarcoma and carcinomas: a prospective study. Veterinary and Comparative Oncology. 2017 jun.;15(2):525–533. https://doi.org/10.1111/vco.12196

Author

Børresen, B ; Nielsen, L N ; Jessen, L R ; Kristensen, A T ; Fredholm, M ; Cirera Salicio, Susanna. / Circulating let-7g is down-regulated in Bernese Mountain dogs with disseminated histiocytic sarcoma and carcinomas : a prospective study. I: Veterinary and Comparative Oncology. 2017 ; Bind 15, Nr. 2. s. 525–533.

Bibtex

@article{64541db6b04d4b08accfec1e45372f27,
title = "Circulating let-7g is down-regulated in Bernese Mountain dogs with disseminated histiocytic sarcoma and carcinomas: a prospective study",
abstract = "Cancer is a prevalent cause of mortality in Bernese mountain dogs (BMDs). Circulating microRNAs (miRNAs) are found in blood and have been identified as promising biomarkers in various neoplastic diseases in humans. In the current study, the expression profile of different types of miRNAs was investigated in healthy BMDs and BMDs with cancer. Seven healthy and six non-treated BMDs with cancer [four with disseminated histiocytic sarcomas (DHS)] were enrolled in this study. Clinical evaluations including physical examination, blood analysis, urinalysis and diagnostic imaging were performed on all dogs. Twenty-four different miRNAs were profiled from RNA isolated from whole blood preserved in PAXgene({\textregistered}) tubes using quantitative real-time PCR (qPCR). The miRNA let-7g was significantly down-regulated in dogs with cancer (P = 0.002) and dogs with DHS (P = 0.011) compared with healthy controls. This miRNA is a known tumour suppressor and further analyses are warranted to assess its value as a non-invasive biomarker for early detection of different types of cancer in BMDs.",
author = "B B{\o}rresen and Nielsen, {L N} and Jessen, {L R} and Kristensen, {A T} and M Fredholm and {Cirera Salicio}, Susanna",
note = "{\textcopyright} 2016 John Wiley & Sons Ltd.",
year = "2017",
month = jun,
doi = "10.1111/vco.12196",
language = "English",
volume = "15",
pages = "525–533",
journal = "Veterinary and Comparative Oncology",
issn = "1476-5810",
publisher = "Wiley-Blackwell",
number = "2",

}

RIS

TY - JOUR

T1 - Circulating let-7g is down-regulated in Bernese Mountain dogs with disseminated histiocytic sarcoma and carcinomas

T2 - a prospective study

AU - Børresen, B

AU - Nielsen, L N

AU - Jessen, L R

AU - Kristensen, A T

AU - Fredholm, M

AU - Cirera Salicio, Susanna

N1 - © 2016 John Wiley & Sons Ltd.

PY - 2017/6

Y1 - 2017/6

N2 - Cancer is a prevalent cause of mortality in Bernese mountain dogs (BMDs). Circulating microRNAs (miRNAs) are found in blood and have been identified as promising biomarkers in various neoplastic diseases in humans. In the current study, the expression profile of different types of miRNAs was investigated in healthy BMDs and BMDs with cancer. Seven healthy and six non-treated BMDs with cancer [four with disseminated histiocytic sarcomas (DHS)] were enrolled in this study. Clinical evaluations including physical examination, blood analysis, urinalysis and diagnostic imaging were performed on all dogs. Twenty-four different miRNAs were profiled from RNA isolated from whole blood preserved in PAXgene(®) tubes using quantitative real-time PCR (qPCR). The miRNA let-7g was significantly down-regulated in dogs with cancer (P = 0.002) and dogs with DHS (P = 0.011) compared with healthy controls. This miRNA is a known tumour suppressor and further analyses are warranted to assess its value as a non-invasive biomarker for early detection of different types of cancer in BMDs.

AB - Cancer is a prevalent cause of mortality in Bernese mountain dogs (BMDs). Circulating microRNAs (miRNAs) are found in blood and have been identified as promising biomarkers in various neoplastic diseases in humans. In the current study, the expression profile of different types of miRNAs was investigated in healthy BMDs and BMDs with cancer. Seven healthy and six non-treated BMDs with cancer [four with disseminated histiocytic sarcomas (DHS)] were enrolled in this study. Clinical evaluations including physical examination, blood analysis, urinalysis and diagnostic imaging were performed on all dogs. Twenty-four different miRNAs were profiled from RNA isolated from whole blood preserved in PAXgene(®) tubes using quantitative real-time PCR (qPCR). The miRNA let-7g was significantly down-regulated in dogs with cancer (P = 0.002) and dogs with DHS (P = 0.011) compared with healthy controls. This miRNA is a known tumour suppressor and further analyses are warranted to assess its value as a non-invasive biomarker for early detection of different types of cancer in BMDs.

U2 - 10.1111/vco.12196

DO - 10.1111/vco.12196

M3 - Journal article

C2 - 26792388

VL - 15

SP - 525

EP - 533

JO - Veterinary and Comparative Oncology

JF - Veterinary and Comparative Oncology

SN - 1476-5810

IS - 2

ER -

ID: 155995293